Product Information
MEGESTROL ACET 40 MG/ML SUSP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1361 per ML under NDC 70954089610. Its NADAC has been published 110 times since Aug 28, 2024.
FDA first approved this application on Feb 16, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954089610
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEGESTROL ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA077404FDA Approved
2/16/2006
TE Code
AB
On Market Since
7/2/2024
Pharmacological Classes
Price Statistics
The NADAC for MEGESTROL ACET 40 MG/ML SUSP has been published 110 times since Aug 28, 2024, and over the history we have for it it has risen 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1361 per ML |
|---|---|
| All-time high | $0.1456 (Jan 14, 2026) |
| All-time low | $0.1239 (Aug 28, 2024) |
| 52-week high | $0.1456 |
| 52-week low | $0.1355 |
| Median price | $0.1396 |
| Average price | $0.1391 |
| Largest weekly change | +9.9% (Oct 23, 2024) |
| Weeks tracked | 110 |
| Tracking since | Aug 28, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Megestrol Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEGESTROL ACET 40 MG/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MEGESTROL ACET 40 MG/ML SUSP, manufactured by ANI Pharmaceuticals, Inc., is $0.1361 per ML (NDC 70954089610), effective Sep 30, 2026.
How has the price of MEGESTROL ACET 40 MG/ML SUSP changed over time?
Over the history we have for it, the NADAC for MEGESTROL ACET 40 MG/ML SUSP has risen 9.8%. It has been tracked across 110 weekly CMS publications since Aug 28, 2024.
What are the highest and lowest recorded NADAC prices for MEGESTROL ACET 40 MG/ML SUSP?
Since Aug 28, 2024, the NADAC for MEGESTROL ACET 40 MG/ML SUSP has ranged from a low of $0.1239 (Aug 28, 2024) to a high of $0.1456 (Jan 14, 2026), with a median of $0.1396 per ML.
Are there cheaper alternatives to MEGESTROL ACET 40 MG/ML SUSP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEGESTROL ACET 40 MG/ML SUSP, is $0.1290 per ML — about 5% below MEGESTROL ACET 40 MG/ML SUSP.
Who manufactures MEGESTROL ACET 40 MG/ML SUSP?
MEGESTROL ACET 40 MG/ML SUSP (NDC 70954089610) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.